Steven Boyd - Net Worth and Insider Trading
Steven Boyd Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steven Boyd owns 21 companies in total, including Cyclo Therapeutics Inc (CYTH) , Reshape Lifesciences Inc (RSLS) , and Tenax Therapeutics Inc (TENX) among others .
Click here to see the complete history of Steven Boyd’s form 4 insider trades.
Insider Ownership Summary of Steven Boyd
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYTH | Cyclo Therapeutics Inc | 2020-08-27 | 10 percent owner |
| RSLS | Reshape Lifesciences Inc | 2020-09-23 | 10 percent owner |
| TENX | Tenax Therapeutics Inc | 2021-07-08 | director |
 | | 2021-08-16 | director & 10 percent owner |
| | 2020-07-28 | director & 10 percent owner |
| | 2019-09-26 | 10 percent owner |
| | 2019-02-05 | 10 percent owner |
| | 2020-03-16 | 10 percent owner |
| | 2020-02-14 | 10 percent owner |
| | 2021-07-27 | director & 10 percent owner |
| | 2019-12-20 | 10 percent owner |
| | 2019-09-25 | 10 percent owner |
| | 2019-09-23 | 10 percent owner |
| | 2019-05-30 | 10 percent owner |
| | 2019-01-18 | 10 percent owner |
| | 2018-01-22 | 10 percent owner |
| | 2018-08-15 | 10 percent owner |
| | 2018-09-20 | 10 percent owner |
| | 2018-02-02 | 10 percent owner |
| | 2017-03-21 | 10 percent owner |
| | 2021-06-15 | 10 percent owner |
Steven Boyd Trading Performance
Steven Boyd Ownership Network
Steven Boyd Owned Company Details
What does Cyclo Therapeutics Inc do?
Who are the key executives at Cyclo Therapeutics Inc?
Steven Boyd is the 10 percent owner of Cyclo Therapeutics Inc. Other key executives at Cyclo Therapeutics Inc include 10 percent owner Rafael Holdings, Inc. , director & Chief Executive Officer Jeffrey Tate , and SVP for Medical Affairs Sharon Hemond Hrynkow .
Cyclo Therapeutics Inc (CYTH) Insider Trades Summary
Over the past 18 months, Steven Boyd made no insider transaction in Cyclo Therapeutics Inc (CYTH). Other recent insider transactions involving Cyclo Therapeutics Inc (CYTH) include a net purchase of 4,000,000 shares made by Rafael Holdings, Inc. ,
In summary, during the past 3 months, insiders sold 0 shares of Cyclo Therapeutics Inc (CYTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclo Therapeutics Inc (CYTH) were sold and 4,000,000 shares were bought by its insiders, resulting in a net purchase of 4,000,000 shares.
Cyclo Therapeutics Inc (CYTH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclo Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Reshape Lifesciences Inc do?
Who are the key executives at Reshape Lifesciences Inc?
Steven Boyd is the 10 percent owner of Reshape Lifesciences Inc. Other key executives at Reshape Lifesciences Inc include Chief Financial Officer Thomas Stankovich , President and CEO Barton P. Bandy , and director & Chairman & President and CEO Dan W Gladney .
Reshape Lifesciences Inc (RSLS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Reshape Lifesciences Inc (RSLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Reshape Lifesciences Inc (RSLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Reshape Lifesciences Inc (RSLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Reshape Lifesciences Inc Insider Transactions
- Download to Excel(.xls)
What does Tenax Therapeutics Inc do?
Who are the key executives at Tenax Therapeutics Inc?
Steven Boyd is the director of Tenax Therapeutics Inc. Other key executives at Tenax Therapeutics Inc include Interim CFO Eliot M Lurier , director & CEO Chrisopher Thomas Giordano , and Chief Medical Officer Stuart Rich .
Tenax Therapeutics Inc (TENX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Tenax Therapeutics Inc (TENX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tenax Therapeutics Inc (TENX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Tenax Therapeutics Inc (TENX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tenax Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Avalo Therapeutics Inc do?
Who are the key executives at Avalo Therapeutics Inc?
Steven Boyd is the director & 10 percent owner of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .
Avalo Therapeutics Inc (AVTX) Insider Trades Summary
Over the past 18 months, Steven Boyd made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 34,840 shares made by Caissa Capital Management Ltd. , a net sale of 3,683,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 4,000 shares made by Garry Arthur Neil .
In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 1,000 shares, with a net purchase of 1,000 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 1,164 shares were bought by its insiders, resulting in a net sale of 14,184 shares.
Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avalo Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Tetraphase Pharmaceuticals Inc do?
Who are the key executives at Tetraphase Pharmaceuticals Inc?
Steven Boyd is the director & 10 percent owner of Tetraphase Pharmaceuticals Inc. Other key executives at Tetraphase Pharmaceuticals Inc include director & See Remarks Larry G. Edwards , director & 10 percent owner Armistice Capital Master Fund Ltd. , and director & 10 percent owner Armistice Capital, Llc .
Tetraphase Pharmaceuticals Inc (TTPH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Tetraphase Pharmaceuticals Inc (TTPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tetraphase Pharmaceuticals Inc (TTPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Tetraphase Pharmaceuticals Inc (TTPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tetraphase Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Vaxart Inc do?
Who are the key executives at Vaxart Inc?
Steven Boyd is the 10 percent owner of Vaxart Inc. Other key executives at Vaxart Inc include Chief Financial Officer Phillip E Lee , Interim CFO Fuad Ahmad , and SVP & General Counsel Edward B Berg .
Vaxart Inc (VXRT) Insider Trades Summary
Over the past 18 months, Steven Boyd made no insider transaction in Vaxart Inc (VXRT). Other recent insider transactions involving Vaxart Inc (VXRT) include a net purchase of 20,000 shares made by W. Mark Watson ,
In summary, during the past 3 months, insiders sold 0 shares of Vaxart Inc (VXRT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vaxart Inc (VXRT) were sold and 20,000 shares were bought by its insiders, resulting in a net purchase of 20,000 shares.
Vaxart Inc (VXRT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vaxart Inc Insider Transactions
- Download to Excel(.xls)
What does Aytu BioPharma Inc do?
Who are the key executives at Aytu BioPharma Inc?
Steven Boyd is the 10 percent owner of Aytu BioPharma Inc. Other key executives at Aytu BioPharma Inc include Chief Financial Officer Mark K Oki , Chief Operating Officer Christopher Brooke , and Chief Business Officer Jarrett Disbrow .
Aytu BioPharma Inc (AYTU) Insider Trades Summary
Over the past 18 months, Steven Boyd made no insider transaction in Aytu BioPharma Inc (AYTU). Other recent insider transactions involving Aytu BioPharma Inc (AYTU) include a net purchase of 14,000 shares made by Joshua R. Disbrow ,
In summary, during the past 3 months, insiders sold 0 shares of Aytu BioPharma Inc (AYTU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aytu BioPharma Inc (AYTU) were sold and 14,000 shares were bought by its insiders, resulting in a net purchase of 14,000 shares.
Aytu BioPharma Inc (AYTU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aytu BioPharma Inc Insider Transactions
- Download to Excel(.xls)
What does AMAG Pharmaceuticals Inc do?
Who are the key executives at AMAG Pharmaceuticals Inc?
Steven Boyd is the 10 percent owner of AMAG Pharmaceuticals Inc. Other key executives at AMAG Pharmaceuticals Inc include 10 percent owner Camber Capital Management Lp , Chief Operating Officer Anthony Casciano , and Interim CFO Brian Piekos .
AMAG Pharmaceuticals Inc (AMAG) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of AMAG Pharmaceuticals Inc (AMAG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AMAG Pharmaceuticals Inc (AMAG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
AMAG Pharmaceuticals Inc (AMAG)'s detailed insider trading history can be found in Insider Trading Tracker table.
AMAG Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Innovus Pharmaceuticals Inc do?
Who are the key executives at Innovus Pharmaceuticals Inc?
Steven Boyd is the 10 percent owner of Innovus Pharmaceuticals Inc. Other key executives at Innovus Pharmaceuticals Inc include 10 percent owner Armistice Capital, Llc , 10 percent owner Armistice Capital Master Fund Ltd. , and EVP & CORPORATE DEVELOPMENT Randy Berholtz .
Innovus Pharmaceuticals Inc (INNV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Innovus Pharmaceuticals Inc (INNV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Innovus Pharmaceuticals Inc (INNV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Innovus Pharmaceuticals Inc (INNV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Innovus Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Kiora Pharmaceuticals Inc do?
Who are the key executives at Kiora Pharmaceuticals Inc?
Steven Boyd is the director & 10 percent owner of Kiora Pharmaceuticals Inc. Other key executives at Kiora Pharmaceuticals Inc include EVP of Finance Melissa Tosca , Chief Development Officer Eric Joseph Daniels , and director & President and CEO Brian M. Strem .
Kiora Pharmaceuticals Inc (KPRX) Insider Trades Summary
Over the past 18 months, Steven Boyd made no insider transaction in Kiora Pharmaceuticals Inc (KPRX). Other recent insider transactions involving Kiora Pharmaceuticals Inc (KPRX) include a net purchase of 2,100 shares made by Melissa Tosca , a net purchase of 5,260 shares made by Erin Parsons , and a net purchase of 5,000 shares made by Praveen Tyle .
In summary, during the past 3 months, insiders sold 0 shares of Kiora Pharmaceuticals Inc (KPRX) in total and bought 4,250 shares, with a net purchase of 4,250 shares. During the past 18 months, 0 shares of Kiora Pharmaceuticals Inc (KPRX) were sold and 22,291 shares were bought by its insiders, resulting in a net purchase of 22,291 shares.
Kiora Pharmaceuticals Inc (KPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kiora Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Valeritas Holdings Inc do?
Who are the key executives at Valeritas Holdings Inc?
Steven Boyd is the 10 percent owner of Valeritas Holdings Inc. Other key executives at Valeritas Holdings Inc include 10 percent owner Armistice Capital, Llc , 10 percent owner Armistice Capital Master Fund Ltd. , and 10 percent owner Cr Group L.p. .
Valeritas Holdings Inc (VLRXQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Valeritas Holdings Inc (VLRXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Valeritas Holdings Inc (VLRXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Valeritas Holdings Inc (VLRXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Valeritas Holdings Inc Insider Transactions
- Download to Excel(.xls)
What does Del Frisco′s Restaurant Group Inc do?
Who are the key executives at Del Frisco′s Restaurant Group Inc?
Steven Boyd is the 10 percent owner of Del Frisco′s Restaurant Group Inc. Other key executives at Del Frisco′s Restaurant Group Inc include 10 percent owner Armistice Capital, Llc , 10 percent owner Armistice Capital Master Fund Ltd. , and President & Grille Coleman Brandon Charles Iii .
Del Frisco′s Restaurant Group Inc (DFRG) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Del Frisco′s Restaurant Group Inc (DFRG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Del Frisco′s Restaurant Group Inc (DFRG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Del Frisco′s Restaurant Group Inc (DFRG)'s detailed insider trading history can be found in Insider Trading Tracker table.
Del Frisco′s Restaurant Group Inc Insider Transactions
- Download to Excel(.xls)
What does Traws Pharma Inc do?
Who are the key executives at Traws Pharma Inc?
Steven Boyd is the 10 percent owner of Traws Pharma Inc. Other key executives at Traws Pharma Inc include CHIEF MEDICAL OFFICER Victor M Moyo , VP Corp Dev & Gen Counsel Abraham N. Oler , and Chief Medical Officer Steven M Fruchtman .
Traws Pharma Inc (TRAW) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Traws Pharma Inc (TRAW) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Traws Pharma Inc (TRAW) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Traws Pharma Inc (TRAW)'s detailed insider trading history can be found in Insider Trading Tracker table.
Traws Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does Achieve Life Sciences Inc do?
Who are the key executives at Achieve Life Sciences Inc?
Steven Boyd is the 10 percent owner of Achieve Life Sciences Inc. Other key executives at Achieve Life Sciences Inc include CFO and PFO John Bencich , director & President & CEO Richard Alistair Stewart , and 10 percent owner Dialectic Life Sciences Spv Llc .
Achieve Life Sciences Inc (ACHV) Insider Trades Summary
Over the past 18 months, Steven Boyd made no insider transaction in Achieve Life Sciences Inc (ACHV). Other recent insider transactions involving Achieve Life Sciences Inc (ACHV) include a net purchase of 15,000 shares made by John Bencich , and a net purchase of 10,000 shares made by Richard Alistair Stewart .
In summary, during the past 3 months, insiders sold 0 shares of Achieve Life Sciences Inc (ACHV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achieve Life Sciences Inc (ACHV) were sold and 25,000 shares were bought by its insiders, resulting in a net purchase of 25,000 shares.
Achieve Life Sciences Inc (ACHV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Achieve Life Sciences Inc Insider Transactions
- Download to Excel(.xls)
What does Bio-Path Holdings Inc do?
Who are the key executives at Bio-Path Holdings Inc?
Steven Boyd is the 10 percent owner of Bio-Path Holdings Inc. Other key executives at Bio-Path Holdings Inc include director & President & CEO & CFO Peter Henry Nielsen , 10 percent owner Armistice Capital, Llc , and 10 percent owner Armistice Capital Master Fund Ltd. .
Bio-Path Holdings Inc (BPTH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Bio-Path Holdings Inc (BPTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bio-Path Holdings Inc (BPTH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Bio-Path Holdings Inc (BPTH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bio-Path Holdings Inc Insider Transactions
- Download to Excel(.xls)
What does Fresh Tracks Therapeutics Inc do?
Who are the key executives at Fresh Tracks Therapeutics Inc?
Steven Boyd is the 10 percent owner of Fresh Tracks Therapeutics Inc. Other key executives at Fresh Tracks Therapeutics Inc include Chief Medical Officer Monica E. Luchi , director & CHAIRMAN OF THE BOARD Reginald L Hardy , and General Counsel and CCO David R. Mcavoy .
Fresh Tracks Therapeutics Inc (FRTX) Insider Trades Summary
Over the past 18 months, Steven Boyd made no insider transaction in Fresh Tracks Therapeutics Inc (FRTX). Other recent insider transactions involving Fresh Tracks Therapeutics Inc (FRTX) include a net sale of 110 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of Fresh Tracks Therapeutics Inc (FRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 110 shares of Fresh Tracks Therapeutics Inc (FRTX) were sold and 1,086,412 shares were bought by its insiders, resulting in a net purchase of 1,086,302 shares.
Fresh Tracks Therapeutics Inc (FRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fresh Tracks Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Cassava Sciences Inc do?
Who are the key executives at Cassava Sciences Inc?
Steven Boyd is the 10 percent owner of Cassava Sciences Inc. Other key executives at Cassava Sciences Inc include SVP & General Counsel Robert Christopher Cook , Chief Clinical Dev. Officer James William Kupiec , and Chief Financial Officer Eric Schoen .
Cassava Sciences Inc (SAVA) Insider Trades Summary
Over the past 18 months, Steven Boyd made no insider transaction in Cassava Sciences Inc (SAVA). Other recent insider transactions involving Cassava Sciences Inc (SAVA) include a net purchase of 30,000 shares made by Sanford Robertson , and a net purchase of 18,477 shares made by Richard Barry .
In summary, during the past 3 months, insiders sold 0 shares of Cassava Sciences Inc (SAVA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cassava Sciences Inc (SAVA) were sold and 48,477 shares were bought by its insiders, resulting in a net purchase of 48,477 shares.
Cassava Sciences Inc (SAVA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cassava Sciences Inc Insider Transactions
- Download to Excel(.xls)
What does Seelos Therapeutics Inc do?
Who are the key executives at Seelos Therapeutics Inc?
Steven Boyd is the 10 percent owner of Seelos Therapeutics Inc. Other key executives at Seelos Therapeutics Inc include director & See Remarks Raj Mehra , Chief Financial Officer Michael Joseph Golembiewski , and SVP & Chief Business Officer Neil Morton .
Seelos Therapeutics Inc (SEELQ) Insider Trades Summary
Over the past 18 months, Steven Boyd made no insider transaction in Seelos Therapeutics Inc (SEELQ). Other recent insider transactions involving Seelos Therapeutics Inc (SEELQ) include a net purchase of 83,000 shares made by Michael Joseph Golembiewski , and a net purchase of 75,757 shares made by Raj Mehra .
In summary, during the past 3 months, insiders sold 0 shares of Seelos Therapeutics Inc (SEELQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Seelos Therapeutics Inc (SEELQ) were sold and 1,240 shares were bought by its insiders, resulting in a net purchase of 1,240 shares.
Seelos Therapeutics Inc (SEELQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Seelos Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Alimera Sciences Inc do?
Who are the key executives at Alimera Sciences Inc?
Steven Boyd is the 10 percent owner of Alimera Sciences Inc. Other key executives at Alimera Sciences Inc include 10 percent owner Caligan Partners Lp , 10 percent owner David Edward Johnson , and other: Chairman Emeritus C. Daniel Myers .
Alimera Sciences Inc (ALIM) Insider Trades Summary
Over the past 18 months, Steven Boyd made no insider transaction in Alimera Sciences Inc (ALIM). Other recent insider transactions involving Alimera Sciences Inc (ALIM) include a net sale of 0 shares made by Caligan Partners Lp ,
In summary, during the past 3 months, insiders sold 0 shares of Alimera Sciences Inc (ALIM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 579,000 shares of Alimera Sciences Inc (ALIM) were sold and 579,000 shares were bought by its insiders, resulting in a net sale of 0 shares.
Alimera Sciences Inc (ALIM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alimera Sciences Inc Insider Transactions
- Download to Excel(.xls)
What does Dynatronics Corp do?
Who are the key executives at Dynatronics Corp?
Steven Boyd is the 10 percent owner of Dynatronics Corp. Other key executives at Dynatronics Corp include Chief Financial Officer Gabriel Ellwein , director & Chief Executive Officer John Anthony Krier , and Chief Operating Officer Brian D. Baker .
Dynatronics Corp (DYNT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Dynatronics Corp (DYNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dynatronics Corp (DYNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Dynatronics Corp (DYNT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dynatronics Corp Insider Transactions
- Download to Excel(.xls)
What does Reshape Lifesciences Inc do?
Who are the key executives at Reshape Lifesciences Inc?
Steven Boyd is the 10 percent owner of Reshape Lifesciences Inc. Other key executives at Reshape Lifesciences Inc include Chief Financial Officer Thomas Stankovich , director & President and CEO Paul F. Hickey , and 10 percent owner Armistice Capital, Llc .
Reshape Lifesciences Inc (RSLS) Insider Trades Summary
Over the past 18 months, Steven Boyd made no insider transaction in Reshape Lifesciences Inc (RSLS). Other recent insider transactions involving Reshape Lifesciences Inc (RSLS) include a net purchase of 16,686 shares made by Thomas Stankovich ,
In summary, during the past 3 months, insiders sold 0 shares of Reshape Lifesciences Inc (RSLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 18 shares of Reshape Lifesciences Inc (RSLS) were sold and 305 shares were bought by its insiders, resulting in a net purchase of 288 shares.
Reshape Lifesciences Inc (RSLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Reshape Lifesciences Inc Insider Transactions
- Download to Excel(.xls)
Steven Boyd Mailing Address
Above is the net worth, insider trading, and ownership report for Steven Boyd. You might contact Steven Boyd via mailing address: 510 Madison Avenue, 7th Floor, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
